New insider activity at Stryker ( (SYK) ) has taken place on February 4, 2025.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Director Ronda Stryker has made a significant move by selling 201,392 shares of Stryker stock, bringing in approximately $78.99 million from the transaction.
Recent Updates on SYK stock
Recent developments surrounding Stryker’s stock indicate positive investor sentiment, reflected by multiple analysts raising their price targets. Argus increased its price target based on a smooth transition in the CFO position, along with strategic moves like the acquisition of Inari Medical and divestiture of the Spinal Implants business, which are expected to enhance growth and ROI. Truist also raised its target, acknowledging Stryker’s standing as a top-tier MedTech growth company but noted that its profitability trails behind other large-cap peers, suggesting a need for margin expansion and EPS acceleration. Additionally, the divestiture of the spinal implants business is seen as potentially beneficial for competitors like Alphatec, highlighting a shift in the competitive landscape. Overall, the company’s strong earnings call and strategic initiatives have contributed to increased confidence among analysts.
More about Stryker
YTD Price Performance: 9.08%
Average Trading Volume: 1,375,392
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $149.2B